Syftet med studien är att undersöka huruvida den kontorsarbetande kvinnan blir påverkad av menscykelns hormonella skiftningar i arbetslivet, i termer av arbetsprestation och arbetsmiljö. Därtill undersöks huruvida kvinnan ställer sig till arbetsrelaterade anpassningar med hänsyn till påverkan av de hormonella skiftningarna. Datan är insamlad genom kvantitativ metod i form av enkäter på både svenska och engelska. Enkäterna distribuerades på de sociala plattformarna LinkedIn och Facebook tillsammans med en infografisk bild som innehöll fakta om könshormoners påverkan av kroppen. Resultatet indikerar att de kontorsarbetande kvinnorna är måttligt eller starkt påverkade av menscykelns hormonella skiftningar i arbetet. Dessutom framkommer det att en majoritet av respondenterna är positiva till att implementera arbetsrelaterade anpassningar avseende dessa hormonella förändringar. Baserat på datainsamlingen och de valda teoretiska ramverken kan det konstateras att arbetslivet inte alltid är anpassat utefter kvinnors biologiska förutsättningar, och att kvinnors arbetsmiljö och arbetsprestation skulle förbättras såvida arbetsrelaterade anpassningar genomfördes. Vidare är det möjligt att konstatera att ett arbetsklimat anpassat för båda könen skulle ge en ömsesidig vinning för både kvinnorna och företagen. / The purpose of the study is to examine whether the female office worker is affected by the menstrual cycle’s hormonal fluctuations in the workplace, in terms of work performance and work environment. Additionally, it investigates whether women are receptive to workplace adjustments considering the impact of hormonal fluctuations. The data was collected through a quantitative method using surveys in both Swedish and English. The surveys were distributed on the social platforms LinkedIn and Facebook along with an infographic containing facts about the influence of sex hormones on the body. The results indicate that female office workers are moderately or strongly affected by hormonal fluctuations during the menstrual cycle at work. Furthermore, the results show that the majority of respondents are positive towards workplace adjustments regarding hormonal fluctuations during the menstrual cycle. Based on the data collection and the selected theoretical frameworks, it can be concluded that the workplace is not always tailored to women's biological conditions, and that women's work environment and performance would improve if work-related adaptations were implemented. Furthermore, it can be concluded that a work environment adapted for both genders would provide mutual benefits for both the women and the companies.

Il est connu qu’on retrouve chez les femmes en post-ménopause un risque plus important de développer des maladies oculaires comparativement aux hommes du même groupe d’âge. Il semble que les changements hormonaux, et en particulier la baisse importante des niveaux d’estradiol, secondaires à la sénescence folliculaire constituent un facteur étiologique à long terme. Cela étant, il est légitime de se demander si les variations des niveaux d’hormones sexuelles endogènes peuvent également occasionner des effets à court terme sur les tissus de l’œil. Cette interrogation constitue d’ailleurs le motif principal de l’élaboration de la présente étude. Sachant qu’il se produit chez les femmes non ménopausées des variations continuelles des niveaux d’hormones sexuelles stéroïdiennes au cours de leur cycle menstruel, des femmes en âge de procréer ont été recrutées comme sujets d’étude. Dans un deuxième temps, afin de trouver le paramètre d’intérêt, on a effectué une revue de la documentation scientifique qui révèle un fait bien établi : les estrogènes favorisent la vasodilatation des vaisseaux sanguins par l’intermédiaire du monoxyde d’azote, et permettent, par le fait même, l’accroissement du débit sanguin tissulaire. Or, comment mesurer des variations de débit sanguin dans des tissus oculaires? Comme il est expliqué dans la discussion du présent mémoire, les variations d’oxygénation dans un organe dont le métabolisme est relativement stable sont le reflet de variations de débit sanguin. Grâce à une technique de mesure basée sur la spectroréflectométrie, il est possible de mesurer le taux d’oxyhémoglobine (HbO2) des lits capillaires du disque optique. En observant les variations du taux d’oxyhémoglobine au cours du cycle menstruel chez les sujets, on peut ainsi mesurer l’effet des variations hormonales cycliques sur l’irrigation des tissus oculaires. En somme, l’objectif de cette recherche est de mieux comprendre, en suivant le cycle menstruel des femmes, l’effet des hormones sexuelles endogènes sur l’oxygénation des lits capillaires du disque optique. Étant à la base du métabolisme de l’œil, l’apport en oxygène et en divers substrat véhiculés par la circulation sanguine est important au maintien de la santé oculaire. L’éclaircissement du lien entre les hormones et l’oxygénation de la rétine constituerait un avancement important, puisqu’il permettrait de comprendre pourquoi certaines atteintes oculaires, comme la cécité, touchent davantage les femmes. Les résultats de cette étude ont démontré que le taux d’oxyhémoglobine mesuré dans les lits capillaires du disque optique de l’œil ne subit pratiquement pas de variations significatives durant le cycle menstruel lorsqu’on considère les incertitudes des valeurs mesurées. Également, on observe une variabilité similaire des taux d’oxyhémoglobine mesurés chez les femmes en âge de procréation et chez les hommes du même groupe d’âge. Cela suggère que les changements hormonaux cycliques, qui ne se produisent que chez les femmes, n’occasionnent probablement pas de variation significative mesurable du taux d’oxyhémoglobine. Bref, malgré les effets possibles des estrogènes sur le diamètre artériolaire, il semble que les mécanismes locaux de régulation du débit sanguin tissulaire maintiennent un état d’équilibre propre au tissu irrigué et adapté aux besoins métaboliques locaux. / Postmenopausal women, when compared to men from the same age group, are more prone to develop ocular disease. It is thought that long term hormonal changes caused by ovarian senescence, and especially the drop in estradiol, are the etiological mechanism by which this phenomenon occurs. Whether variations in the levels of endogenous sexual hormones can produce short term effects in the tissues of the eye is less understood and, therefore, constitutes the main reason for carrying out the present study. Given that non menopausal women have repeated short term changes in the levels of sex steroid hormones during their menstrual cycle, we have recruited such women as study subjects. We also reviewed the scientific literature to establish what would be the parameter of interest and found a well characterised phenomenon: estrogens promote vasodilation by increasing nitrogen oxide production and thus promote a rise in blood flow. As to measuring variations in blood flow within the eye, it was explained in the discussion of the present memoir that changes in the oxygenation of an organ with a constant metabolism are induced by changes in the blood flow irrigating that organ. Using a method based on spectroreflectometry, it is possible to measure oxyhaemoglobin levels (HbO2) in the capillaries of the optic disc. By studying the variation of the HbO2 levels during the menstrual cycle, we can appreciate the effect of the cyclic hormonal changes on the ocular blood flow. The supply in oxygen and nutrients brought to an organ by its blood flow is essential for its metabolism. Therefore, the discovery of a correlation between sex hormone levels and the oxygenation of the retina would prove to be an important step towards understanding the higher frequency of certain ocular diseases in postmenopausal women, as compared to men of the same age group. The results of our study show that HbO2 levels in the capillary beds of the optic disc do not undergo statistically significant variations during the menstrual cycle. The same results were found, during a similar observational period, for male subjects used in the study as controls. These results suggest that cyclic variations in the levels of sex hormones, which occur only in nonmenaopausal women, do not induce significant changes in the oxygenation of the optic disc. In short, despite the possible effect of estrogens on the arteriolar diameter, it seems that local regulatory mechanisms of the blood flow maintain a tissue in a state of equilibrium that is adapted to its specific metabolic demand.

During roughly forty years of a woman’s life-span, the fertile female human body prepares itself monthly for the possibility of pregnancy. Science has shown that the fluctuation of the sex steroids progesterone and estrogen have a crucial role in the female body's physiology, determining the menstrual cycle and its general phases. This biological dance of hormones governing the cycle influences a lot of physical, mental and cognitive aspects of life for a fertile ovulating woman. Although the question of whether these changes also affect women's cognitive performance is still unclear, some evidence has been gathered that could bring us closer to answers. Recent research findings show that this hormonal interplay might have a significant role in cognitive and psychological development - modulating brain activity, cognitive performance, higher cognition, emotional status, sensory processing, appetite and more. This thesis aims to uncover to what extent the menstrual cycle affects brain functions, neurobiology, mood, well-being and cognitive performance in menstruating cisgender women.

O uso de álcool entre mulheres é uma questão atual e preocupante, face a maior vulnerabilidade destas aos danos hepáticos, cerebrais, entre outros, quando comparadas aos homens com padrões semelhantes de consumo. Sendo assim, investigaram-se as possíveis variações na farmacocinética do etanol em mulheres, considerando duas fases do ciclo menstrual (pré-folicular e lútea), bem como o uso de anticoncepcionais orais (AO). Participaram voluntários dos sexos feminino (n=22) e masculino (n=14), administrando-lhes 0,3 g/kg de etanol, na forma de uísque. Os resultados indicaram: a) os parâmetros farmacocinéticos do etanol não variam em função do ciclo menstrual (fase pré-folicular e lútea); b) as mulheres que tomavam AO levam menos tempo para atingir a concentração máxima e eliminam o etanol mais rapidamente do que as que não faziam uso; c) não houve diferença nos parâmetros farmacocinéticos entre o grupo de homens e o de mulheres que utilizavam AO, porém os homens apresentam maior velocidade de eliminação do que as mulheres que não faziam uso e d) os parâmetros farmacocinéticos relacionados com a biodisponibilidade (área sob a curva) e com o volume de distribuição não apresentaram diferenças entre os grupos analisados. / After drinking equivalent amounts of alcohol, women appear to be more vulnerable than men to many adverse consequences of alcohol use, including liver and brain damage. This study investigated the influence of menstrual cycle and female sex steroids levels on ethanol pharmacokinetics, as a possible mechanism for these effects. Twenty-two female and 14 male volunteers were given a moderate dose of ethanol (0.3 g/kg) in the morning after an overnight fast. The results indicated: a) no evidence that the tested menstrual cycle phases (pre-follicular and luteal) significantly influence ethanol pharmacokinetics; b) the time required to reach peak BAC was shorter and the ethanol elimination rate was increased for women taking oral contraceptives (OC) as compared to women not taking them; c) there is no difference on ethanol pharmacokinetics between men and women taking OC, but men showed increased ethanol elimination rate compared to women not taking OC; d) no gender-related differences relating to bioavailability of ethanol were found.

Introdução: O objetivo foi avaliar a expressão de algumas proteínas no endométrio durante a fase lútea do ciclo menstrual de mulheres férteis e inférteis, por meio imunoistoquímica de micro-arranjos teciduais (TMA). Métodos: Analisou-se a expressão de dez proteínas em 52 amostras de endométrio obtidas nas fases lútea inicial, intermediária (janela de implantação) e final. Resultados: As proteínas, fator inibidor de leucemia (LIF), fator de crescimento insulinóide tipo 1 (IGF-1), receptor de progesterona (PR), claudina-4, receptor de fator de crescimento vascular endotelial 3 (VEGFR-3) e citoqueratina 7 (CK-7) mostraram-se expressas no endométrio nas fases lútea inicial, intermediária e final. A proteína morfogenética óssea 4 (BMP-4) expressou-se no endométrio nas fases lútea inicial e intermediária. As proteínas citoqueratina 17 (CK-17), substância solúvel 100 (S100) e calretinina não se expressaram no endométrio durante os três períodos avaliados. Houve correlação entre as expressões protéicas de LIF, IGF-1 e PR. As proteínas LIF e BMP-4 foram diferencialmente expressos no endométrio nas fases lútea inicial, intermediária e final. As proteínas claudina-4 e PR não se expressam simultâneamente no endométrio durante a fase lútea. Conclusão: Baseados nos resultados deste estudo podemos sugerir que a presença das proteínas LIF, IGF-1 e PR durante a janela implantacional teria relevância como preditor do adequado desenvolvimento do endométrio. / Introduction: The objective of this study was to evaluate endometrial protein expressions from fertile and infertile women during the luteal phase of the menstrual cycle by immunohistochemistry in tissue microarrays (TMA). Method: The expression of ten proteins obtained from 52 endometrial samples in the initial, mid (window of implantation) and late (premenstrual) phases of the menstrual cycle were evaluated. Results: The proteins leukemia inhibitory factor (LIF), insulin like growth factor 1 (IGF-1), progesterone receptor (PR), claudin-4, vascular endothelial growth factor receptor 3 (VEGFR-3), and cytokeratin 7 (CK-7) were expressed in the endometrium in the three intervals of the luteal phase. Endometrial expression of the morphogenetic bone protein 4 (BMP-4) occurred during the initial and mid luteal phases. Cytokeratin 17, substance 100 and calretinin were not expressed in the luteal phase. There were positive correlations among endometrial expressions of LIF, IGF- 1, and PR. LIF and BMP-4 were differently expressed in the initial, mid and late phases of the luteal phase. Claudin-4 and PR did not express simultaneously during the different intervals of the luteal phase. Conclusion: These findings suggest that positively correlated endometrial expressions of LIF, IGF-1 and PR at the window of implantation could characterize an adequately developed and receptive endometrium.

Introdução: O objetivo foi avaliar a expressão de algumas proteínas no endométrio durante a fase lútea do ciclo menstrual de mulheres férteis e inférteis, por meio imunoistoquímica de micro-arranjos teciduais (TMA). Métodos: Analisou-se a expressão de dez proteínas em 52 amostras de endométrio obtidas nas fases lútea inicial, intermediária (janela de implantação) e final. Resultados: As proteínas, fator inibidor de leucemia (LIF), fator de crescimento insulinóide tipo 1 (IGF-1), receptor de progesterona (PR), claudina-4, receptor de fator de crescimento vascular endotelial 3 (VEGFR-3) e citoqueratina 7 (CK-7) mostraram-se expressas no endométrio nas fases lútea inicial, intermediária e final. A proteína morfogenética óssea 4 (BMP-4) expressou-se no endométrio nas fases lútea inicial e intermediária. As proteínas citoqueratina 17 (CK-17), substância solúvel 100 (S100) e calretinina não se expressaram no endométrio durante os três períodos avaliados. Houve correlação entre as expressões protéicas de LIF, IGF-1 e PR. As proteínas LIF e BMP-4 foram diferencialmente expressos no endométrio nas fases lútea inicial, intermediária e final. As proteínas claudina-4 e PR não se expressam simultâneamente no endométrio durante a fase lútea. Conclusão: Baseados nos resultados deste estudo podemos sugerir que a presença das proteínas LIF, IGF-1 e PR durante a janela implantacional teria relevância como preditor do adequado desenvolvimento do endométrio. / Introduction: The objective of this study was to evaluate endometrial protein expressions from fertile and infertile women during the luteal phase of the menstrual cycle by immunohistochemistry in tissue microarrays (TMA). Method: The expression of ten proteins obtained from 52 endometrial samples in the initial, mid (window of implantation) and late (premenstrual) phases of the menstrual cycle were evaluated. Results: The proteins leukemia inhibitory factor (LIF), insulin like growth factor 1 (IGF-1), progesterone receptor (PR), claudin-4, vascular endothelial growth factor receptor 3 (VEGFR-3), and cytokeratin 7 (CK-7) were expressed in the endometrium in the three intervals of the luteal phase. Endometrial expression of the morphogenetic bone protein 4 (BMP-4) occurred during the initial and mid luteal phases. Cytokeratin 17, substance 100 and calretinin were not expressed in the luteal phase. There were positive correlations among endometrial expressions of LIF, IGF- 1, and PR. LIF and BMP-4 were differently expressed in the initial, mid and late phases of the luteal phase. Claudin-4 and PR did not express simultaneously during the different intervals of the luteal phase. Conclusion: These findings suggest that positively correlated endometrial expressions of LIF, IGF-1 and PR at the window of implantation could characterize an adequately developed and receptive endometrium.

A diferença da percepção álgica entre homens e mulheres é, há muito, conhecida e documentada na literatura. Sabe-se também que a sensibilidade feminina varia durante o ciclo menstrual, o que levou à hipótese de que os hormônios ovarianos poderiam estar envolvidosnesse processo. Assim, este estudo teve como objetivo investigar os limiares de sensibilidade somestésica (térmica, dolorosa, tátil, vibratória e elétrica), gustativa e olfativa durante o ciclo menstrual de mulheres saudáveis e a sua relação com as concentrações dos hormônios estrógeno e progesterona na saliva. Foram avaliadas 39 mulheres com idade entre 19 e 47 anos, com ciclos menstruais regulares e sem morbidades associadas à dor. Todas as mulheres foram orientadas quanto aos propósitos desta pesquisa, e somente participaram do estudo aquelas que preencheram os critérios de inclusão e assinaram o termo de consentimento livre e esclarecido. A avaliação foi realizada em três momentos do ciclo menstrual: fase menstrual, fase folicular e fase lútea. Em cada uma dessas fases foram utilizados os seguintes métodos: coleta da saliva no início de cada sessão, para avaliação dos níveis hormonais; avaliação de fluxo salivar; avaliação sensitiva superficial (dor, tato - IITC Woodland Hills, EUA; frio, calor - MSA II e vibratórios - Somedic, Suécia) aplicada na região do ramo maxilar do nervo trigêmeo e na região do antebraço, ambas no lado direito da paciente; e avaliação das sensibilidades gustativa (doce - glicose, salgado - cloreto de sódio, azedo - ácido cítrico e amargo - ureia) e olfativa (isopropanol em diferentes concentrações). Foram observadas oscilações sensitivas em todas as modalidades de acordo com o momento do ciclo menstrual das mulheres avaliadas, sendo que níveis baixos de estrógeno se associaram a altos limiares de dor de profundidade no braço (p=0,008) e na face (p=0,041), altos limiares táteis (p=0,001) e álgicos superficiais (p=0,006) na face. Em contrapartida, altos níveis de progesterona se associaram a altos limiares de dor de profundidade na face (p=0,033) e altos limiares do sabor salgado (p < 0,001). Concluímos que o estrógeno e a progesterona estão envolvidos na neuromodulação da sensibilidade somestésica, gustativa e olfativa de mulheres, durante o ciclo menstrual / There is a sexual difference on pain perception that is supported by the scientific literature. Moreover, sexual hormones seem to be involved in the modulation of sensory detection and there is evidence of sensory variation during the menstrual cycle. Thus, the aim of this study was to investigate the somatosensory (thermal, painful, tactile, vibratory and electric), gustatory (salty, bitter, sweet, sour) and olfactory thresholds during the menstrual cycle in healthy women and verify association with saliva concentration of estradiol and progesterone. We evaluated 39 women aged between 19 and 47 years, with regular menstrual cycles and with no comorbidities related to pain.All women were instructed about the purposes of the study and only those that signed the informed consent were included. The evaluation wasperformed in three moments of the cycle: menstrual phase, follicular phase and luteal phase. In each of these stages, the following methods were used: saliva collection at the beginning of each session, to assess hormone levels; salivary flow measurement; somatosensory evaluation with quantitative sensory testing (pain, tactile - IITC Woodland Hills, USA; cold and warm - MSA II; and vibration - Somedic, Sweden) applied to the right maxillary branch region of the trigeminal nerve and right forearm region; and gustative (sweet - glucose, salt - sodium chloride, sour - citric acid and bitter - urea) and olfactory (isopropanol at different concentrations) thresholds. All sensory thresholds showed fluctuation during the menstrual cycle. Lower estrogen levels were correlated tohigher deep pain thresholds at the forearm (p=0.008) and face (p=0.041); they were also associated with higher tactile thresholds (p=0.001) and higher superficial pain (p=0.006) thresholds at face.High levels of progesterone were associated with high deep pain threshold at the face and high salty threshold (p < 0.001). In conclusion, estrogen and progesterone seems to be involved in sensory neuromodulation in women, during the menstrual cycle

A via sexual é a principal forma de transmissão inter-humana da infecção pelo vírus da imunodeficiência humana (HIV). Com o incremento do número de mulheres infectadas por esse agente retroviral, o estudo de particularidades da biologia do vírus no trato genital feminino adquiriu maior importância. Com o objetivo de avaliar a excreção genital do HIV ao longo do ciclo menstrual, coletaram-se, nas diversas fases de dois ciclos, lavados cervicovaginais de 17 mulheres soropositivas para essa infecção e acompanhadas em serviço ambulatorial especializado de São Paulo. O RNA viral livre foi quantificado por RT-PCR e o DNA proviral por PCR em tempo real, empregando sistema TaqMan. Avaliou-se ainda a carga viral plasmática de HIV, o número de células CD4+ periféricas e presença de co-infecção genital. Detectou-se excreção de RNA-HIV e de DNA proviral, respectivamente, em 18,8% e 31,3% das pacientes. Todas as pacientes que apresentaram excreção de RNA viral também exibiram a de DNA proviral, incluindo paciente com viremia de HIV indetectável. Não houve variação significativa da excreção genital do vírus durante o ciclo menstrual. Em 6 dessas pacientes, que apresentaram co-infecção genital previamente à admissão no estudo, avaliou-se também a excreção genital de HIV quando da co-infecção. Em 2 casos, a excreção genital do DNA-HIV foi superior na vigência de co-infecção causada por Streptococcus sp e Ureaplasma. Não se observou excreção de RNA viral livre nas pacientes co-infectadas. Os resultados obtidos podem contribuir para o entendimento do potencial de transmissibilidade sexual da infecção por HIV e reiteram a necessidade de adesão às práticas de sexo protegido para evitar sua transmissão inter-humana / The sexual route is the main means of transmission of the human immunodeficiency virus (HIV). With the increasing numbers of HIV-infected women, the investigation of particular biological features of HIV infection in the genital tract has become more important. To evaluate HIV genital shedding during the menstrual cycle, we collected cervicovaginal lavages (CVL) from 17 women, assisted at an HIV outpatient clinic in São Paulo, in different hormonal phases during 2 cycles. HIV-RNA and proviral DNA shedding were quantified using RT-PCR and a TaqMan real-time PCR assay, respectively. In addition, patients were screened for genital coinfections and had their HIV plasma viral loads and CD4+ cell counts assessed. Cell-free HIV-RNA and proviral DNA shedding were found in 18.8% and 31.3% of women. All patients who shed HIV-RNA were also shown to present detectable proviral DNA in their CVL, including one woman with undetectable HIV plasma viral load. No significant difference in viral shedding was seen among menstrual cycle phases. Six patients from the cohort, who exhibited genital coinfections previous to admission to the study, had their HIV genital shedding compared at time of coinfection and after its resolution. In two of them proviral DNA shedding was higher at the time of coinfection, caused by Streptococcus sp and Ureaplasma. No cell-free HIV-RNA shedding was detected in coinfected patients. Our results may contribute to the understanding of HIV sexual infectivity from women and emphasize the need for adherence to protected sexual practices in order to avoid viral transmission.

A via sexual é a principal forma de transmissão inter-humana da infecção pelo vírus da imunodeficiência humana (HIV). Com o incremento do número de mulheres infectadas por esse agente retroviral, o estudo de particularidades da biologia do vírus no trato genital feminino adquiriu maior importância. Com o objetivo de avaliar a excreção genital do HIV ao longo do ciclo menstrual, coletaram-se, nas diversas fases de dois ciclos, lavados cervicovaginais de 17 mulheres soropositivas para essa infecção e acompanhadas em serviço ambulatorial especializado de São Paulo. O RNA viral livre foi quantificado por RT-PCR e o DNA proviral por PCR em tempo real, empregando sistema TaqMan. Avaliou-se ainda a carga viral plasmática de HIV, o número de células CD4+ periféricas e presença de co-infecção genital. Detectou-se excreção de RNA-HIV e de DNA proviral, respectivamente, em 18,8% e 31,3% das pacientes. Todas as pacientes que apresentaram excreção de RNA viral também exibiram a de DNA proviral, incluindo paciente com viremia de HIV indetectável. Não houve variação significativa da excreção genital do vírus durante o ciclo menstrual. Em 6 dessas pacientes, que apresentaram co-infecção genital previamente à admissão no estudo, avaliou-se também a excreção genital de HIV quando da co-infecção. Em 2 casos, a excreção genital do DNA-HIV foi superior na vigência de co-infecção causada por Streptococcus sp e Ureaplasma. Não se observou excreção de RNA viral livre nas pacientes co-infectadas. Os resultados obtidos podem contribuir para o entendimento do potencial de transmissibilidade sexual da infecção por HIV e reiteram a necessidade de adesão às práticas de sexo protegido para evitar sua transmissão inter-humana / The sexual route is the main means of transmission of the human immunodeficiency virus (HIV). With the increasing numbers of HIV-infected women, the investigation of particular biological features of HIV infection in the genital tract has become more important. To evaluate HIV genital shedding during the menstrual cycle, we collected cervicovaginal lavages (CVL) from 17 women, assisted at an HIV outpatient clinic in São Paulo, in different hormonal phases during 2 cycles. HIV-RNA and proviral DNA shedding were quantified using RT-PCR and a TaqMan real-time PCR assay, respectively. In addition, patients were screened for genital coinfections and had their HIV plasma viral loads and CD4+ cell counts assessed. Cell-free HIV-RNA and proviral DNA shedding were found in 18.8% and 31.3% of women. All patients who shed HIV-RNA were also shown to present detectable proviral DNA in their CVL, including one woman with undetectable HIV plasma viral load. No significant difference in viral shedding was seen among menstrual cycle phases. Six patients from the cohort, who exhibited genital coinfections previous to admission to the study, had their HIV genital shedding compared at time of coinfection and after its resolution. In two of them proviral DNA shedding was higher at the time of coinfection, caused by Streptococcus sp and Ureaplasma. No cell-free HIV-RNA shedding was detected in coinfected patients. Our results may contribute to the understanding of HIV sexual infectivity from women and emphasize the need for adherence to protected sexual practices in order to avoid viral transmission.

O objetivo deste trabalho foi analisar a influência do ciclo menstrual nas alterações de limiar de dor à pressão (LDP) na musculatura mastigatória de mulheres com sinais e sintomas de Disfunção Temporomandibular (DTM). Inicialmente 47 voluntárias entre 18 e 40 anos participaram do estudo, das quais 36 foram incluídas no experimento: 15 com sinais e sintomas de DTM (7 sob terapia com contraceptivos orais (CO) e 8 sem CO) e 21 saudáveis, sem sinais e/ou sintomas de DTM (8 com CO e 13 sem CO). Os LDPs dos músculos masseter e temporais (anterior, médio e posterior), e do tendão de Aquiles foram medidos bilateralmente, por meio de um algômetro, durante 2 ciclos menstruais consecutivos, nas 4 diferentes fases: menstrual (dias 1-3), folicular (dias 5-9), periovulatória (dias 12-16) e lútea (dias 19-23). Em cada fase do ciclo, as voluntárias relataram sua dor em uma Escala de Análise Visual (EVA). Os resultados foram submetidos à análise de variância a 3 critérios para mensurações repetidas, a um nível de significância de 5%.Foram encontrados LDPs significativamente menores nos músculos temporal e masseter e no tendão de Aquiles das mulheres com DTM quando comparado às mulheres assintomáticas, independentemente da fase do ciclo e do uso de contraceptivos (p < 0,05). De uma maneira geral, os LDPs foram maiores em mulheres em terapia com contraceptivos orais, quando comparado às mulheres sem terapia. Parece não existir influência das diferentes fases do ciclo menstrual no LDP, independentemente da presença ou não de DTM. / The aim of this study was to investigate the influence of the menstrual cycle on the Pain Pressure Threshold (PPT) figures of the masticatory muscles in women with signs and symptoms of Temporomandibular Disorders (TMD). Forty-seven volunteers (ages between 18-40 years-old) were initially recruited for this purpose. According to the criteria adopted, 36 were included. The experimental group was composed of 15 women with myofascial pain (RDC/TMD) (7 under oral contraceptive medication), while 21 women with no TMD signs or symptoms (8 under oral contraceptive medication) composed the control group. The PPT values of masseter and temporalis (anterior, middle, and posterior regions) muscles, as well as the Achilles? tendon were bilaterally screened during two consecutive menstrual cycles, in the following phases: menstrual (day 1-3), follicular (day 5-9), periovulatory (day 12-16) and luteal (day 19-23). A visual analog scale (VAS) was used to address subjective pain in each menstrual phase. Data were submitted to 3-way ANOVA for repeated measurements, with a 5% significant level. The PPT values were significantly lower in the temporalis, masseter, and the Achilles? tendon of TMD patients when compared with the asymptomatic controls, regardless of the menstrual cycle phase or the use of oral contraceptives (p<.05). Overall, the PPT values were higher for patients under oral contraceptive therapy, while VAS was, in general higher at the menstrual phase (p<.05). It appears that the different phases of menstrual cycle have no influence on the PPT values, regardless of the presence of a previous condition, as myofascial pain.